Future Challenges in Biopharmaceutical Workforce Development White Paper

For over 25 years Steve’s career focused on all aspects of downstream processing for biopharmaceuticals which includes process development, from early-stage innovation to late-stage optimization, scale up/tech transfer/ GMP manufacturing, process characterization, process validation, and viral clearance validation studies.

At Syner-G as a Senior consultant in CMC/Biologics Steve brings this wide range of technical experience to assist clients in driving their process development and manufacturing needs from Phase I to Commercial.